id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-267979-k70gnrdw	Yıldız-Peköz, Ayca	Advances in Pulmonary Drug Delivery	2020-09-23		.txt	text/plain	3257	159	38	This Special Issue brings together recent advances in the areas of inhalation device testing, aerosol formulation development, use of in vitro and in silico models in pulmonary drug deposition and drug disposition studies, and pulmonary delivery of complex drugs, such as vaccines, antibiotics and peptides, to or via the lungs. The development of modern-day inhalers, e.g., pressurised metered-dose inhalers (pMDIs) and more recently, dry powder inhalers (DPIs), jet and vibrating mesh nebulisers (VMNs), and soft mist inhalers (SMIs), has given pulmonary drug delivery a momentum boost that transformed a therapeutic niche into a market predicted to hit US$41.5 billion by 2026 [1] . Development of an innovative, carrier-based dry powder inhalation formulation containing spray-dried meloxicam potassium to improve the in vitro and in silico aerodynamic properties Excipient interactions in glucagon dry powder inhaler formulation for pulmonary delivery Inhalable dry powder of bedaquiline for pulmonary tuberculosis: In vitro physicochemical characterization, antimicrobial activity and safety studies	./cache/cord-267979-k70gnrdw.txt	./txt/cord-267979-k70gnrdw.txt